Results for: teva+pharmaceutical+industries

Teva’s Sell Rating From Berenberg Bucks Bullish View on Copaxone

Pfizer $33 Billion Question Remains After Teva, Actavis Feelers

Ahead of the Bell: Biogen shares keep climbing

FDA accepts application for new Sanofi MS drug

Pharmaceutical giant Teva announces departure of CEO

Exclusive: Mylan near multibillion-dollar deal for Abbott drug assets -...

Ranbaxy, Teva settle New York antitrust drug claims

In quest for next windfall, tech funds look to healthcare

U.S. justices uphold firms' religious objections to contraception

Exclusive: Express Scripts presses for more drug savings with coverage list

AstraZeneca loses German court appeal over Seroquel XR drug patent

$2.25M penalty for Missouri pharmaceuticals plant

Israeli drug maker in uproar over planned layoffs